IPO Calendar
Lead Manager
- J P Morgan Chase (490)
- Goldman Sachs (463)
- Morgan Stanley (421)
- Bank of America Merrill Lynch (358)
- Citigroup (222)
- Jefferies (214)
- Credit Suisse (180)
- Barclays (151)
- Cowen and Company (147)
- Deutsche Bank (84)
- Leerink Partners (70)
- Piper Jaffray (70)
- Stifel (65)
- UBS Investment Bank (53)
- Evercore (52)
- RBC Capital (51)
- BMO Capital (49)
- Wells Fargo (47)
- Raymond James (38)
- William Blair (37)
More +
IPO - Pricing (9)
Piper Jaffray
| UnderWriters* | |||||||||||
| Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 11 | Voyager Therape | Health-Care | 14 | 5 | COWN | PPRJ | 25.2% | 26.8% | |||
| Sep 17 | REGENXBIO Inc. | Health-Care | 22 | 6 | BAML | MS | PPRJ | 57.1% | 38.4% | ||
| Aug 5 | Zynerba Pharmac | Health-Care | 14 | 3 | JEFF | PPRJ | 51.2% | 16.1% | |||
| Jul 30 | vTv Therapeutic | Health-Care | 15 | 7 | PPRJ | Stifel | 64.2% | -27.4% | |||
| Jul 2 | Natera Inc. | Health-Care | 18 | 10 | COWN | MS | PPRJ | 136.6% | 26.3% | ||
| Jun 19 | Celyad SA | Health-Care | 68.6 | 1 | PPRJ | UBS | 61.2% | -20.4% | |||
| May 15 | Arcadia Bioscie | Basic-Industries | 8 | 8 | CS | JPM | PPRJ | 1% | 1725% | ||
| May 7 | Collegium Pharm | Health-Care | 12 | 5 | JEFF | PPRJ | 24.2% | 2.4% | |||
| Mar 25 | Cellectis S.A. | Health-Care | 41.5 | 5 | BAML | JEFF | PPRJ | 76.1% | -5.3% | ||
*
Lead manager or one of top three managers in an underwriting team.